Episode

GLP-1 Drugs May Reduce Addiction Risks

Podcast
El Paso News Today | 2 Min News | The Daily News Now!
Published
Jun 8, 2026
Duration seconds
126
Processing state
not_requested
Canonical source
https://api.fastcast.ai/audio/c9bce400-9fb9-4b05-8d5d-5ca7f6110976.mp3
Audio
https://api.fastcast.ai/audio/c9bce400-9fb9-4b05-8d5d-5ca7f6110976.mp3
JSON
/v1/public/podcasts/el-paso-news-today-2-min-news-the-daily-news-now-7476707/episodes/glp-1-drugs-may-reduce-addiction-risks
Markdown
/podcast/el-paso-news-today-2-min-news-the-daily-news-now-7476707/glp-1-drugs-may-reduce-addiction-risks.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/el-paso-news-today-2-min-news-the-daily-news-now-7476707/episodes/glp-1-drugs-may-reduce-addiction-risks/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/el-paso-news-today-2-min-news-the-daily-news-now-7476707/glp-1-drugs-may-reduce-addiction-risks.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

New research reveals GLP-1 weight loss drugs like Ozempic may significantly reduce cravings for alcohol, opioids, nicotine, and cocaine by influencing brain reward pathways — though experts caution this is just a correlation, not proof of causation, and more trials are needed before these drugs could be used to treat addiction. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/50e586ba3c24e8c7